Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …

Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …

Over the last three decades, Acinetobacter has gained importance as a leading nosocomial
pathogen, partly due to its impressive genetic capabilities to acquire resistance and partly …

Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this …

Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most
important multidrug resistant microorganisms in hospitals worldwide. This human pathogen …

Infection due to Acinetobacter baumannii has become a significant challenge to modern
healthcare systems. The organism shows a formidable capacity to develop antimicrobial …

Our experience with managing an outbreak of MDR A baumannii in a medical intensive care
unit (ICU) prompted an evidence-based review of the literature, which resulted in few …

The first decade of the 20th century witnessed a surge in the incidence of infections due to
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …

Abstract Purpose of Review Acinetobacter baumannii (AB) is an infamous nosocomial
pathogen with a seemingly limitless capacity for antimicrobial resistance, leading to few …

Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …